Stephen J. Heyman

Filings by Stephen J. Heyman span 6 companies, the busiest being Onvia Inc, Eden Bioscience Corp and Stephan Co. Between 25 May 2005 and 18 December 2015, the trades on record add up to 34 filings.

On the open market, the record shows 12 purchases worth €756k and 20 sales worth €1.0M. On balance, insiders were net sellers of €282k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2015, the count stands at no purchases and 17 sales.

The median purchase comes to €1,761. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -11.2%. This is a record of the past, not a forecast.

On 21 December 2015 came the latest disclosure, an open-market sale for €968k in Onvia Inc. The most recent open-market purchase was published on 14 January 2010, 6,127 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.